Cargando…
Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022
Autores principales: | O’Laughlin, Kevin, Tobolowsky, Farrell A., Elmor, Riad, Overton, Rahsaan, O’Connor, Siobhán M., Damon, Inger K., Petersen, Brett W., Rao, Agam K., Chatham-Stephens, Kevin, Yu, Patricia, Yu, Yon, Ahmadi, Sarah, Avery, Rachel, Bean, Kathryn, Beavers, Leah, Belanger Giguere, Kim, Brownlee, Joi, Campbell, Catherine, Cheng, Maggie, Clinton, Rachel, Coleman, Taylor, Davis, Monique S., Dubreus, Marie, Henry, Meryl, Lozoya, Sujeith B., Morgan, Jahnae, Muhammad, Kalimah, Parker, Corinne M., Peters, Nigel, Rybak, Ellery, Schwenk, Andrew, van Loben Sels, Jessica, Veillard,, Max |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484807/ https://www.ncbi.nlm.nih.gov/pubmed/36107794 http://dx.doi.org/10.15585/mmwr.mm7137e1 |
Ejemplares similares
-
Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects
por: Das, Tuyelee, et al.
Publicado: (2023) -
Tecovirimat for monkeypox
por: Halani, Sheliza, et al.
Publicado: (2022) -
Monkeypox treatment: Is tecovirimat the answer?
por: Niaz, Faizan, et al.
Publicado: (2022) -
Tecovirimat for the treatment of severe Mpox in Germany
por: Hermanussen, Lennart, et al.
Publicado: (2023) -
The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics
por: van Loben Sels, Jessica M., et al.
Publicado: (2019)